Latest News and Press Releases

Dublin, Dec. 04, 2025 (GLOBE NEWSWIRE) -- The "Clinical Data Analytics Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The Clinical Data Analytics...

Topline results from Phase 2 ZEPHYR trial of ML-007C-MA for schizophrenia expected in the second half of 2026Topline results from Phase 2 VISTA trial of ML-007C-MA for Alzheimer’s disease psychosis...

Science 37 Wins Awards for Excellence in Clinical Trial Delivery, Site Innovation, and Enrollment Acceleration

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) -- The "Human Leukocyte Antigen (HLA) Targeted Therapy, Clinical Trials, Therapeutic Approaches & Market Opportunity Insight 2026" report has been added to...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH) - Global Clinical Trials Review, 2025" clinical trials has been added to ...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Post-Traumatic Stress Disorder (PTSD) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This...

Dublin, Dec. 01, 2025 (GLOBE NEWSWIRE) -- The "Cytopenia - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The report includes an overview...

These patents represent a significant turning point for Propanc and commercial potential of PRP for treating chronic diseases such as cancer and fibrosis

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trials: Comparator Study Trends" report has been added to ResearchAndMarkets.com's offering. This report provides a review of active...

New name reflects company’s transformation as it advances toward the final phase of Lybrido™’s clinical development The Arletta butterfly symbolism underscores commitment to women’s health and...